Pacitti, D; Bax, BE
(2018)
The development of an in vitro cerebral organoid model for investigating the pathomolecular mechanisms associated with the Central Nervous System involvement in Mitochondrial Neurogastrointestinal Encephalomyopathy.
Nucleosides, Nucleotides and Nucleic Acids, 37 (11).
pp. 603-617.
ISSN 1525-7770
https://doi.org/10.1080/15257770.2018.1492139
SGUL Authors: Bax, Bridget Elizabeth
![[img]](https://openaccess.sgul.ac.uk/110022/1.hassmallThumbnailVersion/Submitted%20manuscript%20Pacitti%20and%20Bax_NNNA_PP17.pdf) ![](https://openaccess.sgul.ac.uk/110022/1.haspreviewThumbnailVersion/Submitted%20manuscript%20Pacitti%20and%20Bax_NNNA_PP17.pdf) Preview |
|
PDF
Accepted Version
Available under License ["licenses_description_publisher" not defined].
Download (837kB)
| Preview
|
Abstract
Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE) is a rare disorder caused by mutations in the thymidine phosphorylase gene (TYMP), leading to secondary aberrations to the mitochondrial genome. The disease is characterised by gastrointestinal dysmotility, sensorimotor peripheral neuropathy and leukoencephalopathy. The understanding of the molecular mechanisms that underlie the central nervous system (CNS) is hindered by the lack of a representative disease model; to address this we have developed an in vitro 3-D cerebral organoid of MNGIE.
Induced pluripotent stem cells (iPSCs) generated from peripheral blood mononuclear cells (PBMC) of a healthy control and a patient with MNGIE were characterised to ascertain bona fide pluripotency through the evaluation of pluripotency markers and the differentiation to the germ layers. iPSC lines were differentiated into cerebral organoids. Thymidine phosphorylase expression in PBMCs, iPSCs and Day 92 organoids was evaluated by immunoblotting and intact organoids were sampled for histological evaluation of neural markers. iPSCs demonstrated the expression of pluripotency markers SOX2 and TRA1-60 and the plasticity to differentiate into the germ layers. Cerebral organoids stained positive for the neural markers GFAP, O4, Tuj1, Nestin, SOX2 and MBP. Consistent with the disease phenotypes, MNGIE cells did not display thymidine phosphorylase expression whereas control PBMCs and Day 92 organoids did. Remarkably, control iPSCs did not stain positive for thymidine phosphorylase. We have established for the first time a MNGIE iPSC line and cerebral organoid model, which exhibited the expression of cells relevant to the study of the disease, such as neural stem cells, astrocytes and myelinating oligodendrocytes.
Statistics
Item downloaded times since 01 Aug 2018.
Actions (login required)
![Edit Item](/style/images/action_view.png) |
Edit Item |